Chronic Kidney Disease

BOSTON — Patients with chronic kidney disease reported the COVID-19 pandemic negatively affected their mental health and quality of health care, according to a poster presented at the National Kidney Foundation Spring Clinical Meetings.

BOSTON — Language barriers to educational materials are an issue patients self-identified as “Hispanic/Latinx” face when considering home dialysis, according to a study presented at the National Kidney Foundation Spring Clinical Meetings.

WASHINGTON — In this Healio video exclusive, Javed Butler, MD, MPH, MBA, FACC, FAHA, FESC, discusses the results of the DIAMOND trial of patiromer for the reduction of hyperkalemia in patients with HF with reduced ejection fraction.

BOSTON — Trial results show patiromer is effective in controlling hyperkalemia and helps to reduce the risk of using blood pressure medications in patients with chronic kidney disease and heart failure.

BOSTON — New research presented during the late-breaking trials program at the National Kidney Foundation Spring Clinical Meetings showed the anemia drug daprodustat has cardiovascular benefits comparable to erythropoiesis-stimulating agents.

WASHINGTON — Finerenone was beneficial in primary and secondary prevention across the spectrum of patients with chronic kidney disease and type 2 diabetes regardless of whether they had atherosclerotic CVD, researchers reported.

BOSTON — Transplant programs erect several bureaucratic roadblocks that can stall efforts by patients to obtain a kidney transplant, a speaker said at the National Kidney Foundation Spring Clinical Meetings.

WASHINGTON — The dual SGLT inhibitor sotagliflozin reduced total CV death, MI and stroke in adults with type 2 diabetes and chronic kidney disease both with and without prior CVD, according to new analyses of the SCORED trial.

A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic variants underlying inherited kidney diseases, according to data published in the American Journal of Nephrology.

Satellite Healthcare Inc. and Dialyze Direct executed a letter of intent to enter a strategic partnership collaboration with plans to expand dialysis in the United States, according to a press release.